CMS Compliance Group

Ftag of the Week – Revised F886 COVID-19 Testing-Residents & Staff

This week’s Ftag of the Week on the CMSCG Blog covers important revisions to F886 COVID-19 Testing – Residents & Staff, which we previously reviewed in our “Ftag of the Week” series around this same time last year. (You can view the original regulatory requirements in Part 1 and Part 2 of our Ftag of the Week posts for F886). The updates to F886 has been released in several versions of the Centers for Medicare & Medicaid Services (CMS) QSO Memo, “Interim Final Rule (IFC), CMS-3401-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency related to Long-Term Care (LTC) Facility Testing Requirements,” and this latest version of the regulatory requirements for COVID-19 testing in nursing homes are part of the recently updated QSO-20-38-NH with a revision date of 9/10/2021.

F886 – Updated Definitions

The revisions to F886 now include definitions for:

The definitions of “close contact” and “higher-risk exposure” align with the CDC’s September 10, 2021 update to its Infection Control: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) webpage which includes updated testing intervals for individuals who have had higher-risk exposures and close contact.

Testing Updates

The updated QSO Memo follows Interim Guidance from the CDC that was updated on September 10, 2021, “Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes,” which includes updates to outbreak response. The updated guidance promotes the use of contact tracing during outbreak investigations, as well as provides alternatives for outbreak responses. This means that when a single new positive case of COVID-19 is identified in any resident or staff member, the facility should begin an outbreak investigation immediately, using one of two approaches (contact tracing or broad-based testing).


The Testing Trigger Summary Table has been updated to the following:


So, as you can see, there is more flexibility given to facilities with strong contact tracing capabilities in place. If a facility cannot identify close contacts of the individual who tested positive, then facility-wide testing must be conducted just as in prior guidance.

Routine Testing

The criteria for routine testing has also been updated. The guidance now states that routine testing for residents is “not generally recommended.” For staff, the following guidance should be followed:

Facilities should monitor their level of community transmission every other week and adjust the frequency of performing staff testing accordingly. If the level of community transmission increases, the facility should begin testing its staff at the expected frequency as soon as the criteria for the higher level is met. Conversely, if the community transmission decreases, the facility is still expected to test staff at the higher level frequency until the level of community transmission has remained at the lower level for at least two weeks before the testing frequency can be reduced. So, to reduce testing frequency, if a facility is in a “substantial” level of transmission county and the county drops into the “moderate” level, the facility needs to watch the community transmission level for two weeks to ensure it stays at the “moderate” level before it can reduce the testing to what is required for the “moderate” level.


While many facilities have chosen to go above and beyond the required minimum testing as part of their own policies, this is now the minimum expectation for testing:


Other Key Points about Staff Testing

Since F886 was updated to align with current CDC guidance, there are several other important items to note.

First, as of September 10, 2021, the CDC updated its “Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2.”  Providers should view this guidance, as well as the previously mentioned guidance, for preventing the spread of SARS-CoV-2 in nursing homes when testing staff who have had a higher-risk exposure to COVID-19 when the facility is not in outbreak status.

Second, as mentioned, facilities now have the ability to conduct focused testing based on known close contacts of an individual with COVID-19. This is only feasible if the facility has the capabilities to identify all close contacts. If this is not possible, then the expectation is to complete an outbreak investigation at either the facility-wide scale or at the group level, such as a floor or unit. It is noted that facilities may need to test more broadly if:

Third, for staff who test positive for COVID-19, repeat testing is not recommended to end work restrictions. The facility should follow this CDC guidance.

To read the full revisions to F886, view the updated CMS QSO Memo (Ref: QSO-20-38-NH) here.

Exit mobile version